Nalaganje...
The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies
BACKGROUND: A previous six-week (wk) study demonstrated the potential of the sodium-glucose linked transport inhibitor velagliflozin as a novel treatment for equine insulin dysregulation. The present study examined the safety and efficacy of velagliflozin over 16 wk. of treatment, and over 4 wk. of...
Shranjeno v:
| izdano v: | BMC Vet Res |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6390376/ https://ncbi.nlm.nih.gov/pubmed/30808423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-019-1811-2 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|